Mark Jeffrey DeLong - 18 Mar 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Mark DeLong
Issuer symbol
APLS
Transactions as of
18 Mar 2024
Net transactions value
-$564,050
Form type
4
Filing time
19 Mar 2024, 16:03:44 UTC
Previous filing
13 Feb 2024
Next filing
13 Aug 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $564,050 -9,913 -15% $56.90 54,693 18 Mar 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.